APA (7th ed.) Citation

Takumi Satoh, Dorit Trudler, Chang-Ki Oh, & Stuart A. Lipton. (2022). Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. MDPI AG.

Chicago Style (17th ed.) Citation

Takumi Satoh, Dorit Trudler, Chang-Ki Oh, and Stuart A. Lipton. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID Through NRF2 Activation to Counteract the NLRP3 Inflammasome. MDPI AG, 2022.

MLA (9th ed.) Citation

Takumi Satoh, et al. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID Through NRF2 Activation to Counteract the NLRP3 Inflammasome. MDPI AG, 2022.